:format(jpeg):focal(466x138:476x128)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/JQ7TVBVN4BCGBEX4LFCLPZUTOQ.jpg)
A group of researchers from MIT, West Virginia University and Celero Systems, in the United States, created an ingestible capsule that allows vital signs to be monitored from inside a patient’s digestive tract. The intention is to allow cases of sleep apnea or opioid overdose to be evaluated non-invasively and, eventually, use that same capsule to administer some medication.
According to MIT, the capsule is the size of a vitamin pill, it has an accelerometer (similar to what modern phones have to detect when we rotate the screen) to measure the patient’s heart rate and breathing rate based on the vibrations that these movements generated inside the body, two small batteries and an antenna to transmit the data it records wirelessly to an external computer.
The capsule is designed to take its measurements in the stomach, because it is close to the heart and lungs, but it also fulfills its function in the rest of the digestive tract. In fact, they explain, the records coincide with those provided by conventional skin sensors. And they estimate that it takes a little more than a day to be expelled from the body.
What we were able to demonstrate is that, using the capsule, we could capture data that matched what traditional transdermal sensors would capture, Traverso says. “We also observed that the capsule was able to detect apnea, and that was confirmed with standard monitoring systems available in the sleep laboratory.” In studies, they found that the capsule is used to analyze both sleep apnea and opioid overdose.
In future work, the researchers hope to incorporate an anti-overdose medication such as nalmefene into the device, so that the release of the drug is triggered when the person’s breathing rate slows or stops. They are also working on strategies to lengthen the time the capsules could remain in the stomach.
This is the first time these types of smart pills have been tested in human patients to measure apnea, although it is not the first case of a pill that is, in effect, a minicomputer that is swallowed. In 2018, tests were carried out with a capsule similar to the one at MIT, although its objective was not to measure sleep apnea, but rather the state of the intestinal flora.
The pill in question detects and measures in real time the gases present in the intestine, such as hydrogen, carbon dioxide or oxygen, data that can be sent to a cell phone. Early trials revealed previously unobserved mechanisms in the body and a potential new immune system, according to Royal Melbourne Institute of Technology. The trials with this smart pill also revealed the presence of “large concentrations of oxygen” in the colon if a diet high in fiber is followed, which contradicts “the old beliefs” that this element was not present in said organ.
This year, meanwhile, they introduced NaviCam, a pill that is controlled externally using a magnet, and that could replace endoscopies. Researchers at the University of Washington created a pill-sized device that has a camera on the tip, an internal battery and a transmitter. And it allows, as with an endoscopy, to explore the human body from the inside; sends the images taken by the camera with an internal antenna.
